awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48089393-80B4C097-DE08-476D-BB79-2CD1D85B68A6
Q48089393-80B4C097-DE08-476D-BB79-2CD1D85B68A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48089393-80B4C097-DE08-476D-BB79-2CD1D85B68A6
Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update.
P2860
Q48089393-80B4C097-DE08-476D-BB79-2CD1D85B68A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48089393-80B4C097-DE08-476D-BB79-2CD1D85B68A6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8e7cf73e481c8642af7da088993fbeca2e1815d8
P2860
The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE)